On August 28, 2023, the Federal Circuit issued a decision in In re Cellect, LLC, affirming the Patent Trial and Appeal Board’s (PTAB) cancellation of claims for obviousness-type double patenting (ODP)...
IP knowledge at work for you. Biotechnology
To ensure our clients receive the highest level of service, we aggressively recruit business-minded attorneys and scientists from diverse technical backgrounds who understand and speak the language of biotechnology.
Whether you are an early-stage company, an established company with a commercial product, a research institution, or an investor in life sciences, our biotech team understands the business and legal framework in which you operate. Let us help you achieve your IP goals.
Our group’s services include: IP strategic planning; patent prosecution and portfolio development, acquisition and enforcement; studies on patentability, infringement and validity; IP audits and due diligence; licensing and technology transfer; defending and challenging patent validity, including post-grant proceedings; and freedom to operate and competitor analyses.
Our clients include leading biotech companies such as Biogen, Moderna, Takeda, Ginkgo Bioworks, and Oxford Nanopore Technologies, investment firms, and prestigious academic and research institutions, including Dana-Farber Cancer Institute, Harvard Medical School, and MIT. We understand the different needs of each client and bring practical solutions to the table.
We have extensive experience in a broad range of areas from antibodies to gene and cell therapies—and everything in between. We often team with members of our other practices, including Chemical & Materials Technologies and Pharmaceutical, when their knowledge benefits your project. Experienced paralegals and a team of international filing specialists help contain costs and deliver value for you.
Many early-stage companies turn to us as their IP counsel, often staying a client through high growth periods and even beyond their acquisition. We frequently point out very real applications of their technology in industries beyond their field of vision. We also know their competition, both real and potential, and have helped clients raise billions of dollars in funding.
Awards & Recognition
Our team’s advanced degrees include:
- Biomedical Engineering
- Biomedical Sciences
- Cancer Biology
- Cellular Biology
- Chemical Engineering
- Chemical Biology
- Earth and Planetary Sciences
- Medical Biophysics
- Medical Engineering
- Medical Physics
- Molecular Biology
- Molecular Biophysics and Biochemistry
- Molecular Pharmacology and Physiology
- Structural Biology
- Vision Science
Why our clients remain clients for many years.
When you’re growing a company, you have to look at long-term goals. One of the things we often see working with law firms is that there’s very little stability. It’s quite rare to have a longstanding relationship, because people leave and move on to other firms. But the consistency with Wolf Greenfield over the years has been remarkable.
Wolf Greenfield has experts in every scientific area that we have needed.
Wolf Greenfield sets the 'gold standard' for patent prosecution. It is a top firm.
The level of communication we have received from Wolf Greenfield has been excellent.
Outstanding legal and technical knowledge. High degree of responsiveness. Willingness to engage deeply. Always working hard to achieve and find solutions for our business objectives.
They’re highly respected in our community, so they offer me an entrée that few other firms can. This is an outstanding firm and an outstanding team. They are deep, very well-schooled, intelligent, insightful, supportive, cohesive, and team-oriented.
Prosecuted one of the most widely licensed biotechnology patent portfolios, with over 70 licensees.
Obtained a Patent Term Extension of over three years for a biologic, representing over $900 million in projected sales.
For a biotechnology client with a case suspended for years at the USPTO, developed a prosecution strategy to move the case out of suspension, avoiding an interference, and resulting in a dominant patent.
Heather DiPietrantonio Shortlisted for Patent Strategy Honor at LMG Life Sciences Americas Awards 2023
Heather DiPietrantonio, a shareholder in Wolf Greenfield’s Biotechnology Practice, has been selected as a finalist in the “Patent Strategy Attorney of the Year – Massachusetts” category at the LMG Lif...
In its fifth annual Patent Prosecution Intelligence Report, Patexia Inc.—an intellectual property community and information service—has named Wolf Greenfield among the top performing and most active l...